Literature DB >> 19225076

Seroepidemiological study after a long-distance industrial outbreak of legionnaires' disease.

E Wedege1, T Bergdal, K Bolstad, D A Caugant, J Efskind, H E Heier, A Kanestrøm, B H Strand, I S Aaberge.   

Abstract

Following a long-distance outbreak of Legionnaires' disease from an industrial air scrubber in Norway in 2005, a seroepidemiological study measuring levels of immunoglobulin G (IgG) and IgM antibodies to Legionella pneumophila was performed with a polyvalent enzyme-linked immunosorbent assay. One year after the outbreak, IgG levels in employees (n = 213) at the industrial plant harboring the scrubber and in blood donors (n = 398) from the outbreak county were low but significantly higher (P < or = 0.002) than those in blood donors (n = 406) from a nonexposed county. No differences in IgM levels among the three groups were found after adjustment for gender and age. Home addresses of the seroresponders in the exposed county clustered to the city of the outbreak, in contrast to the scattering of addresses of the seroresponding donors in the nonexposed county. Factory employees who operated at an open biological treatment plant had significantly higher IgG and IgM levels (P < or = 0.034) than those working >200 m away. Most of the healthy seroresponders among the factory employees worked near this exposure source. Immunoblotting showed that IgG and IgM antibodies in 82.1% of all seroresponders were directed to the lipopolysaccharide of the L. pneumophila serogroup 1 outbreak strain. In conclusion, 1 year after the long-distance industrial outbreak a small increase in IgG levels of the exposed population was observed. The open biological treatment plant within the industrial premises, however, constituted a short-distance exposure source of L. pneumophila for factory employees working nearby.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225076      PMCID: PMC2668286          DOI: 10.1128/CVI.00458-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  35 in total

1.  Pan-European study on culture-proven Legionnaires' disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups.

Authors:  J H Helbig; S Bernander; M Castellani Pastoris; J Etienne; V Gaia; S Lauwers; D Lindsay; P C Lück; T Marques; S Mentula; M F Peeters; C Pelaz; M Struelens; S A Uldum; G Wewalka; T G Harrison
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-10-18       Impact factor: 3.267

2.  [Legionellas in domestic warm water--effects on the health of residents].

Authors:  U Heudorf; W Hentschel; M Hoffmann; C Lück; R Schubert
Journal:  Gesundheitswesen       Date:  2001-05

3.  Legionella pneumophila serogroup 1 antibody kinetics in patients with Legionnaires' disease: implications for serological diagnosis.

Authors:  Johan Darelid; Sture Löfgren; Bo-Eric Malmvall; Margreth-Ann Olinder-Nielsen; Gunnar Briheim; Hans Hallander
Journal:  Scand J Infect Dis       Date:  2003

4.  Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease.

Authors:  H C Boshuizen; S E Neppelenbroek; H van Vliet; J F Schellekens; J W den Boer; M F Peeters; M A Conyn-van Spaendonck
Journal:  J Infect Dis       Date:  2001-07-16       Impact factor: 5.226

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Nosocomial Legionnaires' disease: a continuing common-source epidemic at Wadsworth Medical Center.

Authors:  C E Haley; M L Cohen; J Halter; R D Meyer
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

7.  The Philadelphia epidemic of Legionnaire's disease: clinical, pulmonary, and serologic findings two years later.

Authors:  G L Lattimer; L V Rhodes; J S Salventi; J P Galgon; V Stonebraker; S Boley; G Haas
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

8.  Detection of specific IgM antibody in the investigation of an outbreak of pneumonia due to Legionella pneumophila serogroup 1.

Authors:  F De Ory; J M Echevarría; C Pelaz; A Téllez; M A Mateo; J López
Journal:  Clin Microbiol Infect       Date:  2000-02       Impact factor: 8.067

9.  Tracking airborne Legionella and Legionella pneumophila at a biological treatment plant.

Authors:  Janet Martha Blatny; Bjørn Anders P Reif; Gunnar Skogan; Oyvind Andreassen; E Arne Høiby; Eirik Ask; Viggo Waagen; Dag Aanonsen; Ingeborg S Aaberge; Dominique A Caugant
Journal:  Environ Sci Technol       Date:  2008-10-01       Impact factor: 9.028

10.  A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999.

Authors:  Jeroen W Den Boer; Ed P F Yzerman; Joop Schellekens; Kamilla D Lettinga; Hendriek C Boshuizen; Jim E Van Steenbergen; Arnold Bosman; Susan Van den Hof; Hans A Van Vliet; Marcel F Peeters; Ruud J Van Ketel; Peter Speelman; Jacob L Kool; Marina A E Conyn-Van Spaendonck
Journal:  Emerg Infect Dis       Date:  2002-01       Impact factor: 6.883

View more
  4 in total

Review 1.  Multi-Scale Airborne Infectious Disease Transmission.

Authors:  Charles F Dillon; Michael B Dillon
Journal:  Appl Environ Microbiol       Date:  2020-12-04       Impact factor: 4.792

2.  Two Legionnaires' disease cases associated with industrial waste water treatment plants: a case report.

Authors:  Jaana Kusnetsov; Liisa-Kaarina Neuvonen; Timo Korpio; Søren A Uldum; Silja Mentula; Tuula Putus; Nhu Nguyen Tran Minh; Kari-Pekka Martimo
Journal:  BMC Infect Dis       Date:  2010-12-02       Impact factor: 3.090

3.  Characterization of the extent of a large outbreak of Legionnaires' disease by serological assays.

Authors:  Øystein Simonsen; Elisabeth Wedege; Anita Kanestrøm; Karin Bolstad; Ingeborg S Aaberge; Eivind Ragnhildstveit; Jetmund Ringstad
Journal:  BMC Infect Dis       Date:  2015-03-28       Impact factor: 3.090

4.  Review Global seroprevalence of legionellosis - a systematic review and meta-analysis.

Authors:  Frances F Graham; Simon Hales; Paul S White; Michael G Baker
Journal:  Sci Rep       Date:  2020-04-30       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.